Cerebra

Cerebra operates at the intersection of AI medical imaging, stroke triage, and emergency-care workflow software. Its differentiation is a narrow focus on non-contrast CT, a modality that is broadly available in emergency departments and can be used without contrast agents. The product set includes ASPECTS, intracranial hemorrhage assessment, and the HEATMAP module, targeting decisions that must be made quickly during suspected stroke cases. This focus gives Cerebra a clearer clinical use case than general-purpose healthcare AI platforms, but it also places the company in a demanding category where regulatory clearance, clinical validation, radiologist trust, and integration with hospital systems are decisive. Public materials cite more than 50 hospitals, over 700 physicians, and operations across three countries, indicating early international traction. Cerebra’s competitive position is therefore best understood as an early-stage, specialized medical-device software company rather than a scaled diagnostic platform.

Cerebra’s trajectory shows a progression from a Kazakhstan-founded stroke-diagnostics initiative in 2018 to a Silicon Valley-based medical-imaging company. Initial financing consisted of three Pre-Seed rounds totaling $300,000 between 2018 and 2020. The company then raised $1 million in Seed funding on Jun 21, 2021 and $1.64 million on Aug 22, 2022. Momentum increased with a $4.1 million Seed round announced on Oct 12, 2023, bringing disclosed funding to $7.04 million across eight rounds when grants and non-equity assistance are included. The 2023 MedTech Innovator support and the February 2024 Health Engine grant added non-dilutive backing alongside equity financing. The April 2024 headquarters relocation is the clearest strategic inflection point, moving the company closer to US hospitals, investors, and regulatory stakeholders. Product development has also become more defined around non-contrast CT analysis, ASPECTS, ICH, and HEATMAP rather than broad medical AI. The company reports a team size of 11–50 employees and is hiring, while its July 2024 advisory-board additions strengthened AI and venture expertise.